I am a postdoctoral researcher at Karolinska Institutet, specializing in cancer research. My work focuses on understanding tumor heterogeneity and developing novel therapeutic strategies. With a background in clinical medicine and extensive experience in translational oncology, I am deeply committed to bridging the gap between scientific discoveries and clinical applications.

Attending the Hong Kong Laureate Forum will provide a unique opportunity to engage with world-class scientists, exchange ideas with fellow young researchers, and explore cutting-edge advancements in biomedical sciences. I aim to gain new insights, foster international collaborations, and contribute to discussions on innovative cancer therapies. This forum will be invaluable in shaping my future research and strengthening global scientific connections.

During my master's and PhD studies, my research focus was on the development and progression of glioblastoma and the mechanisms of chemotherapy resistance, where I gained some understanding of the pathological features and treatment challenges of glioblastoma. In my post-doctoral phase, I explored the mechanisms of tumor heterogeneity and plasticity in neuroblastoma at Karolinska Institute, Sweden. Neuroblastoma, as a highly heterogeneous pediatric tumor, poses unique challenges due to the dynamic interactions and plasticity between its different cell subtypes, significantly affecting disease progression and treatment resistance. I aim to systematically investigate the molecular mechanisms underlying the interswitching between the two major cell types in neuroblastoma and to identify potential therapeutic targets.